About the Company
Neuralstem Inc. is a biotechnology company headquartered in Rockville, Maryland that specializes in developing commercial-scale production of multiple types of central nervous system stem cells. In October 2019 Neuralstem announces that the company has changed its name to Seneca Biopharma, Inc. In April 2021 Seneca Biopharma merged with Leading BioSciences to form the combined company Palisade Bio, Inc.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PALI News
Why Palisade Bio Stock Is Up Today
Palisade Bio, Inc. (NASDAQ:PALI) shares are trading higher Tuesday after the company entered into a collaboration with Strand ...
Palisade Bio stock rallies on Strand Life Sciences partnership
Palisade Bio announced a strategic collaboration with Strand Life Sciences today. Palisade Bio stock opened a whopping 50% up ...
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
Collaboration grants Palisade Bio access to cutting-edge expertise and tools in bioinformatics – Partnership marks a ...
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stool
Company continues advancing ongoing development of targeted therapies for ulcerative colitis (UC) Carlsbad, CA, April 16, ...
Palisade Bio, Strand Life Sciences team up on colitis drug research
Palisade Bio (PALI) stock shot up 26% in pre-market trading Tuesday after the company announced a strategic collaboration with bioinformatics firm Strand Life Sciences. Read more.
Palisade Bio stock rallies nearly 100% on colitis drug analysis
Palisade Bio (PALI) stock shot up nearly 100% after the company released results from an analysis of its drug PALI-2108 in ...
Palisade Bio Inc 7NS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Palisade Bio Announces 1-for-15 Reverse Stock Split
Carlsbad, CA, April 03, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical ...
Analyzing the Price-to-Earnings Ratio of Palisade Bio Inc (PALI)
The stock price of Palisade Bio Inc (NASDAQ: PALI) has jumped by 61.54 compared to previous close of 4.16. Despite this, the company has seen a gain of 23.99% in its stock price over the last five ...
Why Palisade Bio Stock Is Soaring Today
Palisade Bio, Inc. (NASDAQ:PALI) shares are trading higher Tuesday after the company announced the completion of its analysis ...
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and ...
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stool
Carlsbad, CA, April 16, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical ...
Loading the latest forecasts...